Abstract:Abstract Objectives: Epithelial to mesenchymal transition (EMT), which occurs in the initiation of metastasis, offers tumor cells increased invasive properties. MDM2 overexpression has been reported to predict distant metastasis, with mechanisms undefined. The present study will investigate the role of MDM2 in regulating EMT, so as to promote the discovery and development of novel targets for anti-metastasis therapy. Methods: (1) MDM2 expression in human ovarian adenocarcinoma tissues was examined by immunohistochemical staining; (2) SKOV3 cells were transfected with MDM2 plasmid, then the alteration of cell motility was detected using wound-healing and transwell assays; the protein and mRNA expression of E-cadherin and Slug/Snail were detected by Western Blot and real-time PCR respectively; (3) Smad2, Smad3 or Smad4 was silenced by siRNA, then E-cadherin protein expression affected by MDM2 overexpression was determined by Western Blot; (4) After transfection with MDM2 siRNA, TGF-β-triggered activation EMT and cell migration were observed; (5) The effect of MDM2 inhibitor Nutlin-3 on EMT and cell motility were observed by Western Blot and transwell assays. Results: MDM2 expression in 123 clinical samples was examined by immunohistochemical staining, which identified a significant correlation between MDM2 expression and clinical staging. The reduction of E-cadherin protein expression, as the indicator of the occurrence of EMT, was observed in SKOV3 cells transfected with MDM2 plasmid, which led to increased cell motility. In addition, evident upregulation of Slug and Snail expression was induced by MDM2 overexpression. Smad complexes directly activate the transcription of Slug and Snail. In our study, after silencing Smad2, Smad3 or Smad4, the inhibitory effect of MDM2 on E-cadherin expression was counteracted, indicating that Smad pathway might be critical for MDM2-promoted EMT. Then we found that TGF-β-Smad-induced EMT and cell migration could be suppressed by silencing MDM2. Further investigation suggested that the MDM2 inhibitor Nutlin-3 could prevent the downregulation of E-cadherin induced by TGF-β or MDM2 overexpression through interrupting Smad activation. Additionally, Nutlin-3 exhibited inhibitory effect on cell migration, which might be owing to its antagonism on the EMT. Conclusion: In summary, this study explored the molecular mechanisms underlying the role of MDM2 in cancer progression. MDM2 expression has been demonstrated to be closely correlated to human ovarian adenocarcinoma clinical staging, indicating the possible utilization of MDM2 in prognosis. Further study clarified MDM2 promoted tumor cell migration through the induction of EMT, which provides new theoretical evidences for the roles that MDM2 plays in tumor metastasis. Our study implicates that MDM2 may be a potential target for inhibiting metastasis and contributes to the translational research of MDM2 inhibitors as anti-metastatic agents. Citation Format: Lin Zheng, Yeping Wu, Tianyi Zhou, Hong Zhu, Qiaojun He, Bo Yang. MDM2 promotes tumor cell migration through the induction of epithelial to mesenchymal transition. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1434. doi:10.1158/1538-7445.AM2015-1434

DSG2 and C-Myc Interact to Regulate the Expression of ADAM17 and Promote the Development of Cervical Cancer

Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer.

Up-regulated DSG2 promotes tumor growth and reduces immune infiltration in cervical cancer

DSG2 Expression is Correlated with Poor Prognosis and Promotes Early-Stage Cervical Cancer

Elevated CISD2 Expression Predicts Poor Diagnosis and Promotes Invasion and Migration of Prostate Cancer Cells.

Significance of Desmoglein‐2 on Cell Malignant Behaviors Via Mediating MAPK Signaling in Cervical Cancer

Desmoglein-2 is Overexpressed in Non-Small Cell Lung Cancer Tissues and Its Knockdown Suppresses NSCLC Growth by Regulation of P27 and CDK2.

Expression of Syndecan-2 in Gastric Adenocarcinoma and Its Effect on Tumorigenesis in Vitro

Upregulation of Desmoglein 2 and Its Clinical Value in Lung Adenocarcinoma: a Comprehensive Analysis by Multiple Bioinformatics Methods.

Mdm2 Promotes Tumor Cell Migration Through The Induction Of Epithelial To Mesenchymal Transition

CISD2 Promotes Lung Squamous Carcinoma Cell Migration and Invasion Via the TGF-β1-induced Smad2/3 Signaling Pathway.

Abstract 1434: MDM2 Promotes Tumor Cell Migration Through the Induction of Epithelial to Mesenchymal Transition

KMT2A Regulates Cervical Cancer Cell Growth Through Targeting VDAC1.

Musashi-2 is a Prognostic Marker for the Survival of Patients with Cervical Cancer.

Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.

Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.

Down-regulated Desmocollin-2 Promotes Cell Aggressiveness Through Redistributing Adherens Junctions and Activating Beta-Catenin Signalling in Oesophageal Squamous Cell Carcinoma.

Effect of the Regulator of G-protein Signaling 2 on the Proliferation and Invasion of Oral Squamous Cell Carcinoma Cells and Its Molecular Mechanism.

High expression of disabled homolog 2-interacting protein contributes to tumor development and proliferation in cutaneous squamous cell carcinoma

ADAMDEC1 promotes cervical squamous cell carcinoma by enhancing the JAK/STAT signaling pathway through modulation of TYMP

Preliminary Study on the Role of the CSMD2 Gene in Bladder Cancer